References
- World Health Organization. Hepatitis B: fact sheet no 204. Updated July 2016. Accessed August 25th 2016.
- Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Centers for Disease Control and Prevention. 2009; 1–206. Google Scholar
- World Health Organization. Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. World Health Organization Geneva. 2016. Google Scholar
- United Nations Programme on HIV/AIDS. Global AIDS update 2016. Updated July 2016. Accessed August 25th 2016.
- Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases, a systematic review and meta-analysis. Int J Infect Dis. 2010; 14 (12): e1024–31. PubMed | Google Scholar
- Gatanaga H, Yasuoka A, Kikuchi Y, Tachikawa N, Oka S. Influence of prior HIV-1 infection on the development of chronic hepatitis B infection. Eur J Clin Microbiol Infect Dis. 2000; 19(3): 237-9. PubMed | Google Scholar
- Brito M, Alhyraba M. Hepatitis B in patients coinfected with HIV. Hosp Physician. 2008; 20:17–23. Google Scholar
- Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007; 7(6):402 – 9. PubMed | Google Scholar
- Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Muñoz A et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002; 360(9349): 1921-6. PubMed | Google Scholar
- Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005; 19(6): 593-601. PubMed | Google Scholar
- Weber R, Sabin CA, Frils-Møller N, Reiss P, El-Sadr WM, Kirk O et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006; 166(15):1632-41. PubMed | Google Scholar
- Hawkins C, Christian B, Ye J, Nagu T, Aris E, Chalamilla G et al. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania. AIDS. 2013; 27(6):919 – 927. PubMed | Google Scholar
- World Health Organization. Combating Hepatitis B and C to reach elimination by 2030: advocacy brief. Geneva Switzerland, WHO. 2016. Google Scholar
- Fix OK, Locarnini SA, Development M, Peters MG.
Virology and Clinical Management of Hepatitis B and
HIV Coinfection.Physician Research Network. 2007; 11:
20–27.
- Nagu TJ, Bakari M, Matee M. Hapatitis A, B and
C viral co-infections among HIV-infected adults presenting
for care and treatment at Muhimbili National Hospital
in Dar es Salaam, Tanzania.
BMC Public Health. 2008; 8: 416. Google
Scholar
- MOHSW. Expanded Programme on immunization 2006-2010,
Tanzania: Comprehensive Multiyear Plan. Dar es Salaam,
Tanzania, Government Press. 2007; 2nd edition. Google
Scholar
- 1. The United Republic of TanzaniaPresident's Office Regional Administration and Local Government. Moshi Municipality Council: Districts of Kilimanjaro including Moshi Municipal Council . 2013. Accessed September 2016.
- Attia K, Eholié S, Messou E, Danel C, Polneau S, Chenal H et al. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol. 2012; 4(7): 218-223. PubMed | Google Scholar
- Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Afr Health Sci. 2012; 12(3): 312 – 317. PubMed | Google Scholar
- Boyles TH, Cohen K. The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J. 2011; 101(7): 470-471. PubMed | Google Scholar
- Matthews PC, Beloukas A, Malik A, Carlson JM, Jooste P, Ogwu A et al. Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana. PLoS ONE. 2015; 10(7): e0134037. PubMed | Google Scholar
- Baseke J, Musenero M, Mayanja-Kizza H. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda. Afr Health Sci. 2015; 15(2): 322-327. PubMed | Google Scholar
- Matee MI, Magesa E, Lyamuya EF. Seroprevalence
of human immunodeficiency, hepatitis B and C viruses
and Sphiylis infection among blood donors at the Muhimbili
National Hospital in Dar es Salaam,
Tanzania. BMC Public Health. 2006; 6: 21.
- Rashid S, Kilewo C, Abood S. Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at tertiary hospiral in Dar es Salaam, Tanzania. Tanzan J of Health Res. 2014; 16(1): 9-15. PubMed | Google Scholar
- Msuya SE, Mbizvo EM, Hussain A, Sam NE, Stray-Pedersen B. Seroprevalence of Hepatitis B and C viruses among women of childbearing age in Moshi urbun,Tanzania. East Afr Med J. 2006; 83(2):92-94. PubMed | Google Scholar
- Benhamou Y, Bochet M, Thibault V, Di Martino V, Caumes E, Bricaire F et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology. 1999; 30(5):1302-6. PubMed | Google Scholar
- Gu L, Han Y, Li Y, Zhu T, Song X, Huang Y et al. Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China. PLoS ONE. 2015; 10(8):e0134539. PubMed | Google Scholar
- Mauka WI, Mahande MJ, Msuya SE, Philemon RN. Factors
associated with repeated blood donation at the northern
zone blood transfusion centre in Tanzania. Journal
of Blood Transfusion. 2015; 2015:717653. Google
Scholar